Oral Pre-exposure Prophylaxis Uptake and Acceptability Among Men Who Have Sex With Men: A Scoping Review of the Literature.

Perez Livias Moyo, Wilfred Njabulo Nunu
Author Information
  1. Perez Livias Moyo: Department of Environmental Health, Faculty of Environmental Science, National University of Science & Technology, Bulawayo, Zimbabwe. ORCID
  2. Wilfred Njabulo Nunu: Office of the Executive Dean, Faculty of Environmental Science, National University of Science & Technology, Bulawayo, Zimbabwe. ORCID

Abstract

Despite the global effort to end the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) epidemic as a global threat by 2030, the rate of new HIV infections worldwide remains unacceptably high among men who have sex with men, hence the need to use pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection. This population has an increased risk of getting HIV; thus, it is imperative to assess the uptake and acceptability of PrEP. This study investigated the willingness, availability, accessibility, and knowledge and identified barriers and facilitators to using PrEP among this population. A scoping literature review search was conducted on research papers published in English and focused on men who have sex with men and their use of PrEP. These were independently screened and coded. Of about 1,202 literature sources, 55 were included in the study. Findings reported that the uptake and acceptability of PrEP were influenced by knowledge and perception of being high-risk. Generally, PrEP uptake and understanding were high in North America, Latin America, and Europe and low in Asia and Africa. Low uptake and acceptability have been largely attributed to fear of side effects, societal stigma, cost, and perception of not being at risk. Noted facilitators to PrEP use include education, availability of free pills, support groups, and friendly health care facilities. Health intervention programs to increase the use of PrEP must be backed by appropriate legal and regulatory frameworks.

Keywords

References

  1. J AIDS HIV Treat. 2020;2(2):42-50 [PMID: 33693447]
  2. J Int AIDS Soc. 2019 Feb;22(2):e25242 [PMID: 30724470]
  3. Int J Environ Res Public Health. 2021 Apr 29;18(9): [PMID: 33947130]
  4. Isr J Health Policy Res. 2021 Dec 6;10(1):71 [PMID: 34872598]
  5. Ann Intern Med. 2018 Oct 2;169(7):467-473 [PMID: 30178033]
  6. JMIR Public Health Surveill. 2018 Jan 23;4(1):e13 [PMID: 29362213]
  7. Infect Dis Poverty. 2016 Sep 05;5(1):85 [PMID: 27593965]
  8. Int Health. 2022 May 2;14(3):288-294 [PMID: 34325469]
  9. PLoS One. 2019 Aug 22;14(8):e0221558 [PMID: 31437243]
  10. Int J Environ Res Public Health. 2021 Sep 15;18(18): [PMID: 34574652]
  11. J Int AIDS Soc. 2017 Apr 6;20(1):21472 [PMID: 28418232]
  12. Medwave. 2017 Dec 27;17(9):e7117 [PMID: 29286354]
  13. JMIR Med Inform. 2022 May 2;10(5):e33219 [PMID: 35499859]
  14. AIDS Behav. 2018 Apr;22(4):1063-1074 [PMID: 28176168]
  15. AIDS Care. 2019 Oct;31(10):1185-1192 [PMID: 31039628]
  16. PLoS One. 2021 Aug 13;16(8):e0255557 [PMID: 34388155]
  17. Behav Med. 2021 Apr-Jun;47(2):111-119 [PMID: 31851587]
  18. PLoS Med. 2012;9(8):e1001286 [PMID: 22927797]
  19. AIDS Care. 2020 Mar;32(3):330-336 [PMID: 31597455]
  20. AIDS Care. 2017 Jan;29(1):98-104 [PMID: 27329745]
  21. AIDS Patient Care STDS. 2015 Oct;29(10):569-77 [PMID: 26348459]
  22. AIDS Res Ther. 2021 Jul 30;18(1):46 [PMID: 34330300]
  23. South Afr J HIV Med. 2022 Nov 08;23(1):1405 [PMID: 36479416]
  24. PLoS One. 2016 Apr 19;11(4):e0151385 [PMID: 27093430]
  25. AIDS Behav. 2021 Jul;25(7):1993-2004 [PMID: 33389373]
  26. AIDS Behav. 2018 Apr;22(4):1096-1099 [PMID: 29243109]
  27. CMAJ Open. 2021 May 21;9(2):E529-E538 [PMID: 34021010]
  28. AIDS Behav. 2022 Aug;26(8):2676-2685 [PMID: 35133529]
  29. Sex Health. 2018 Feb;15(1):39-45 [PMID: 28859729]
  30. AIDS Behav. 2022 Aug;26(8):2768-2782 [PMID: 35182281]
  31. Biosci Trends. 2016 May 23;10(2):113-9 [PMID: 27052151]
  32. AIDS Care. 2021 Sep;33(9):1228-1236 [PMID: 32603610]
  33. Lancet Public Health. 2020 Sep;5(9):e501-e511 [PMID: 32888443]
  34. PLoS One. 2018 Feb 12;13(2):e0191671 [PMID: 29432470]
  35. Cien Saude Colet. 2022 Oct;27(10):3923-3937 [PMID: 36134798]
  36. AIDS Behav. 2023 Aug;27(8):2606-2616 [PMID: 36670210]
  37. Lancet Reg Health Am. 2022 Feb;6: [PMID: 35291206]
  38. BMJ Open. 2021 Oct 29;11(10):e053634 [PMID: 34716167]
  39. BMC Public Health. 2020 Jan 15;20(1):69 [PMID: 31941469]
  40. Int J Environ Res Public Health. 2022 Mar 17;19(6): [PMID: 35329266]
  41. Afr J AIDS Res. 2017 Dec;16(4):315-320 [PMID: 29132291]
  42. PLoS One. 2022 Apr 5;17(4):e0266280 [PMID: 35381024]
  43. AIDS Patient Care STDS. 2021 May;35(5):158-166 [PMID: 33901403]
  44. Am J Mens Health. 2023 Jul-Aug;17(4):15579883231184078 [PMID: 37395415]
  45. AIDS Patient Care STDS. 2017 Dec;31(12):517-527 [PMID: 29211513]
  46. Lancet Infect Dis. 2014 Sep;14(9):820-9 [PMID: 25065857]
  47. AIDS Care. 2016;28 Suppl 1:44-7 [PMID: 26971540]
  48. AIDS Patient Care STDS. 2016 Jun;30(6):282-90 [PMID: 27220036]
  49. BMC Health Serv Res. 2022 Dec 7;22(1):1491 [PMID: 36476363]
  50. Int J STD AIDS. 2011 May;22(5):256-62 [PMID: 21571973]
  51. AIDS Educ Prev. 2015 Apr;27(2):112-25 [PMID: 25915697]
  52. BMC Public Health. 2020 Aug 20;20(1):1267 [PMID: 32819335]
  53. AIDS Behav. 2023 Apr;27(4):1234-1247 [PMID: 36219270]
  54. PLoS One. 2021 Apr 15;16(4):e0249625 [PMID: 33857195]

MeSH Term

Male
Humans
Homosexuality, Male
HIV Infections
Pre-Exposure Prophylaxis
Sexual and Gender Minorities
Social Stigma
Patient Acceptance of Health Care

Word Cloud

Created with Highcharts 10.0.0PrEPmenHIVuptakeuseacceptabilitysexriskglobalimmunodeficiencyAIDShighamongpre-exposureprophylaxispopulationstudyavailabilityknowledgefacilitatorsliteratureperceptionAmericaDespiteeffortendhumanvirusacquiredsyndromeepidemicthreat2030ratenewinfectionsworldwideremainsunacceptablyhenceneedreduceinfectionincreasedgettingthusimperativeassessinvestigatedwillingnessaccessibilityidentifiedbarriersusingscopingreviewsearchconductedresearchpaperspublishedEnglishfocusedindependentlyscreenedcoded1202sources55includedFindingsreportedinfluencedhigh-riskGenerallyunderstandingNorthLatinEuropelowAsiaAfricaLowlargelyattributedfearsideeffectssocietalstigmacostNotedincludeeducationfreepillssupportgroupsfriendlyhealthcarefacilitiesHealthinterventionprogramsincreasemustbackedappropriatelegalregulatoryframeworksOralPre-exposureProphylaxisUptakeAcceptabilityAmongMenSexMen:ScopingReviewLiterature

Similar Articles

Cited By (5)